文献速递外周血管胸部技术与安全USCT

无症状高危癌症人群的血管影像:血栓筛查与治疗管理的价值

Vascular Imaging in the Asymptomatic High-risk Cancer Population: A Role for Thrombosis Screening and Therapy Management.
PubMed 文献 · J Ultrasound Med · 2021-03-27

本研究基于多中心随机试验PHACS的回顾性分析,纳入117例Khorana评分≥3且开始新全身化疗的无症状癌症患者,基线下肢静脉超声和胸部增强CT筛查的偶发VTE患病率为9%(n=10),其中58%由筛查超声诊断。随机阶段VTE发生率为16%(n=16),对照组21%(n=10)vs 达肝素组12%(n=6),绝对风险降低9%但无统计学意义(HR=0.69,95%CI 0.23-1.89),69%患者无症状,31%由筛查超声诊断。

要点

  • Khorana评分≥3的无症状癌症患者基线下肢静脉超声和胸部增强CT筛查偶发VTE患病率为9%。
  • 随机阶段对照组VTE发生率21% vs 达肝素组12%,绝对风险降低9%但无统计学意义(HR=0.69,95%CI 0.23-1.89)。
  • 筛查发现的VTE患者中69%无症状,31%由筛查超声诊断。

诊断标准与关键数值

  • 基线偶发VTE患病率9%(n=10),其中58%由筛查超声诊断。
  • 随机阶段VTE发生率16%(n=16),对照组21%(n=10)vs 达肝素组12%(n=6),绝对风险降低9%(HR=0.69,95%CI 0.23-1.89),无统计学意义。
  • 随机阶段VTE患者中69%无症状,31%由筛查超声诊断。

临床应用与阅片要点

  • 对Khorana评分≥3的无症状癌症患者,在常规肿瘤监测CT基础上加做筛查超声可提高VTE检出。
  • 筛查发现的VTE多数无症状,阅片时需关注超声和CT上的偶发血栓征象。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We retrospectively examined the venous thromboembolism (VTE) events diagnosed in the Prophylaxis of High-Risk Ambulatory Cancer Patients Study (PHACS), a multi-center randomized trial, to assess the value of screening vascular imaging for the diagnosis of incidental VTE in high-risk cancer patients.

METHODS: A total of 117 asymptomatic cancer patients with a Khorana score ≥3 starting a new systemic chemotherapy regimen were enrolled in a prospective randomized control trial. Patients underwent baseline venous ultrasound (US) of the lower extremities (LEs) and screening contrast-enhanced chest computed tomography (CT). Those without preexisting VTE were then randomized into observation or dalteparin prophylaxis groups and were screened with serial US every 4 weeks for up to 12 weeks and imaged with contrast-enhanced chest CT at 12 weeks. Any additional imaging performed during the study period was also evaluated for VTE.

RESULTS: Baseline prevalence of incidental VTE was 9% (n = 10) with 58% percent of VTEs diagnosed by screening US. Incidence of VTE in the randomized phase of the trial was 16% (n = 16) with 21% (n = 10) of patients in the control arm and 12% (n = 6) of patients in the dalteparin arm developing VTE, a non-significant 9% absolute risk reduction (HR = 0.69, 95% CI 0.23-1.89). Sixty-nine percent of these patients were asymptomatic with 31% of patients diagnosed by screening US.

CONCLUSIONS: Adding screening US to routine oncologic surveillance CT in high-risk ambulatory cancer patients with a Khorana score ≥3 can lead to increased VTE detection, with potential for decreased morbidity, mortality, and health care spending.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Loftus JR, Hu Z, Morin BR, et al. Vascular Imaging in the Asymptomatic High-risk Cancer Population: A Role for Thrombosis Screening and Therapy Management. J Ultrasound Med. 2021. PMID: 33772825. doi:10.1002/jum.15701

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。